Congratulations to Nicolai Wever Albrechtsen on receiving the prestigious Anders Jahre Prize for 2024 for young scientists! His groundbreaking work in glucagon regulation and plasma proteomics continues to advance our understanding of health and disease.
https://t.co/CpHn8VVSLE
The GLUSENTIC test and index assessing dynamic amino acid responses to glucagon may be used to measure glucagon resistance in individuals with #obesity and #MASLD@Diabetes_ADA@Metabolcenter https://t.co/pp7JhFDMpe
For millennia, migraine's origin puzzled scientists. We contributed to the @ScienceMagazine paper showing how cortical spreading depression alters 11% of CSF proteome, including 2-fold increase in CGRP. The proteomic shift may explain aura-headache link. @nicwin98@NedergaardLab
#Glucagon resistance exist in #MASLD but can this be reversed by reducing hepatic steatosis alone or by weight loos? @KjeldsenSasha at @bfhosp investigated this in patients with type 2 diabetes. #obesity and not MASLD may be dictating #glucagonresistance https://t.co/U1ayQ5OFlW
#NAFLD increases the risk of diabetes but what is known about rare but seriost chronic liver diseases like #autoimmune liver disease?
We have for the last 3 years explored this by literature review, metaanalysis and clinical studies.
Here our first take
https://t.co/i9NM6bybhI
Thoughtful and excellent perspective on the issues raised by the unexpected closing of the CPR in Copenhagen by the Novo Nordisk Foundation. Its by our international SAB under the leadership of Angus Lamond. Out in EMBO Reports now.
https://t.co/9pfA844y9M